Recursion Pharmaceuticals Inc【RXRX】株式ニュース | ADVFN

US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Recursion Pharmaceuticals Inc (RXRX)
Recursion Pharmaceuticals Inc (RXRX) ニュース

Recursion Pharmaceuticals Inc (RXRX)

7.29

0.20

( 2.82% )

更新日時： 03:50:54

個人投資家向けのプロ仕様のツール。

プレミアム

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Recursion and Exscientia Shareholders Approve the Proposed Combination

Salt Lake City USA, Oxford UK, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) and Exscientia plc (Nasdaq: EXAI) have each received...

Recursion Announces the Release of OpenPhenom-S/16 in Google Cloud’s Model Garden

SALT LAKE CITY, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio...

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

1
2
次へ

ToucanYoucan

ToucanYoucan 20時間前

$RXRX - That's why I'm planning to steadily accumulate shares - with the hope that one or more of these new treatments materializes.

bwrbad

bwrbad 24時間前

high potential if delivers,

TucsonPhil

TucsonPhil 1日前

Good gains in past week, but looks like it is getting ready to drift lower again.

TucsonPhil

TucsonPhil 1日前

First patient dosed.

https://ir.recursion.com/news-releases/news-release-details/recursion-announces-first-patient-dosed-phase-12-clinical-study

lambchops

lambchops 5日前

Glad to see the uptick! Was beaten down for a while. Too good of stock to be down for long.

LC

RXRX

ToucanYoucan

ToucanYoucan 5日前

$RXRX - Having a huge day here!!

ToucanYoucan

ToucanYoucan 1週前

$RXRX - Nice move up today! This will take a little time to find its footing pps-wise after the merger...imo

TucsonPhil

TucsonPhil 3週前

Many foreign countries supplying pharmaceuticals to U.S. at exorbitant markups.

Will anything be done about that? I do not believe tariffs will help with that problem, since people either pay, whatever the cost, or suffer and die.

Monksdream

Monksdream 1月前

Monksdream

Monksdream 1月前

Monksdream

Monksdream 1月前

mick

abrooklyn

abrooklyn 2月前

https://x.com/RecursionPharma/status/1841453309342740925

TucsonPhil

TucsonPhil 2月前

So many clinical trials in work, but for this to translate to value, they will need to show high efficacy and a much shorter time-to-market, using Recursion platform. The problem may be that Recursion can identify promising candidates quickly, but the slow-moving follow-on processes will still eat up valuable time. The value proposition here is the decrease in attrition, for candidates that fail in early stage trials.

https://ir.recursion.com/news-releases/news-release-details/recursion-gives-guidance-seven-clinical-readouts-within-18

https://www.recursion.com/pipeline

mick

WALL @ $7.5 , $7.0

mick

https://www.stockscores.com/charts/charts/?ticker=RXRX

lambchops

lambchops 3月前

Yes. Good stock to put on watchlist IMO.
Still reasonably cheap. Check MACD.

LC

RXRX

mick

diamond in the ruff

RXRX
Recursion Pharmaceuticals Inc
6.32
0.20 (3.27%)
Volume: 3,082,418
Day Range: 6.055 - 6.32
Last Trade Time: 4:28:47 PM EDT

mick

RXRX
Recursion Pharmaceuticals Inc
5.95
-0.22 (-3.57%)
Volume: 4,577,882
Day Range: 5.895 - 6.30
Last Trade Time: 7:58:59 PM EDT

lambchops

lambchops 3月前

Yes, I've been adding shares of RXRX this week.

LC

RXRX

TucsonPhil

TucsonPhil 3月前

Looks.like a little dilution, but a good buying opportunity, to add some more.

lambchops

lambchops 3月前

Judging on the reaction some investors must not have liked it either.Will be a strong company into RXRX.I like buying good companies that have a downdraft. They usually come back strong.
Please note I own shares in this company.

LC

RXRX

TucsonPhil

TucsonPhil 3月前

I had not seen that merger announcement. Never came across in my broker news feed.

lambchops

lambchops 3月前

Did you see the possible merger news?

LC

RXRX

TucsonPhil

TucsonPhil 3月前

Running millions of tests per week, to find promising drug candidates.

What we do not know, is how many candidates have entered clinical trials.

When news pops about RXRX origination of promising cures, this will skyrocket.

Oops, missed this one:

https://ir.recursion.com/news-releases/news-release-details/recursion-announces-phase-2-data-rec-994-first-disease

lambchops

lambchops 3月前

Looks ready to move IMO.

LC

RXRX

TucsonPhil

TucsonPhil 3月前

Looking for a move into the 9.25-9.50 range within the next few weeks.

lambchops

lambchops 3月前

RXRX looks ready for another move upward.

lambchops

lambchops 3月前

Settling back down.

TucsonPhil

TucsonPhil 3月前

Looks like RXRX is making an upward move.

lambchops

lambchops 3月前

I like RXRX even better!

LC

GOOD to own, Rxrx

lambchops

lambchops 4月前

How do you like RXRX at $6.65?

Monksdream

Monksdream 4月前

TucsonPhil

TucsonPhil 5月前

Hold this one until they discover a promising drug candidate, then play the spike and repurchase on the subsequent slump. Ofc, if they do start identifying promising drug candidates, then it could just keep going up, after proof of concept is shown.

mick

RXRX
Recursion Pharmaceuticals Inc
7.9485
-0.4015 (-4.81%)
Volume: 2,346,108
Day Range: 7.94 - 8.48
Last Trade Time: 2:15:15 PM EDT

Monksdream

Monksdream 6月前

RXRX was bought Friday by Cathie Wood for the.ARKK fund
Based on the chart it’s a buy at $5

mick

Recursion Pharmaceuticals Inc (NASDAQ:RXRX)

https://www.msn.com/en-us/money/markets/hedge-funds-are-loading-up-on-this-nvidia-corp-nvda-partner-stock/ar-BB1njsU8?ocid=BingNewsSerp

https://finviz.com/quote.ashx?t=RXRX&p=d

sutter hill, investor

https://pro.manwardpress.com/p/PARTNERTO99MWLLT2YRDSCBP/NMWL4506/?s1=d0587f1afbc14e9f9b10866ff8e6d8b6&h=true

https://www.insidermonkey.com/blog/7-best-under-the-radar-ai-stocks-hedge-funds-are-buying-1307776/

mick

RXRX
Recursion Pharmaceuticals Inc
8.79
0.21 (2.45%)
Volume: 1,471,309
Day Range: 8.60 - 8.87
Last Trade Time: 12:14:29 PM EDT

mick

9 mos

SEVEN MOS; http://www.stockta.com/

9 mos
[-chart]www.stockscores.com/chart.asp?TickerSymbol=RXRX&TimeRange=275&Interval=d&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=830&ChartHeight=500&LogScale=None&Band=None&avgType1=SMA&movAvg1=50&avgType2=SMA&movAvg2=100&Indicator1=RSI&Indicator2=BBW&Indicator3=AccDist&Indicator4=MACD&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgreen[/chart]

SEVEN MOS; http://www.stockta.com/
[-chart]www.stockta.com/cgi-bin/candle.pl?cobrand=&symb=RXRX&size=analysis&support=0.00,15,0.00,66,0.00,38,0.00,14,0.00,12,0.00,15,0.00,3,0.00,2,0.00,4,0.00,6,0.00,2&trend=[/chart]

mick

Recursion Pharmaceuticals Inc
Clinical-stage biotechnology company Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) saw its stock double on the announcement of a $50 million investment from artificial intelligence (AI) leader Nvidia Co. (Nasdaq: NVDA).
Nvidia Invested $50 million into This AI Drug Discovery Biotech
www.nasdaq.com/articles/nvidia-invested-$50-million-into-this-ai-drug-discovery-biotech
www.nasdaq.com/articles/nvidia-invested-$50-million-into-this-ai-drug-discover…

mick

BioHive-2, an NVIDIA DGX SuperPOD with NVIDIA DGX H100 systems, ranked #35 in the TOP500 list of the most powerful supercomputers in the world across all industries as of May 2024.

mick

Recursion Announces Completion of NVIDIA-Powered BioHive-2, the Largest Supercomputer in Pharmaceutical Industry

mick

https://www.otcmarkets.com/stock/RXRX/news/story?e&id=2857451

rolvram

rolvram 7月前

Earnings on Thursday

TucsonPhil

TucsonPhil 8月前

Was only a matter of time before another company jumped on the bandwagon:

"Dell Technologies and Northwestern Medicine to Advance Patient Care through AI Innovation"

https://www.prnewswire.com/news-releases/dell-technologies-and-northwestern-medicine-to-advance-patient-care-through-ai-innovation-302108735.html

Monksdream

Monksdream 8月前

Monksdream

Monksdream 9月前

Joe of Nanolyze explains RXRX

Monksdream

Monksdream 9月前

jokolahd3

jokolahd3 10月前

In a 100 trilliona biology yes

jokolahd3

jokolahd3 11月前

Looks like 5 dollars is a good buy

Recursion Pharmaceuticals

Green Visor Financial Te...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約